Molecular bases underlying the hepatoprotective effects of coffee

Nutrients

Volumn 9, Issue 1, 2017, Pages

  Salomone, Federico ^a   Galvano, Fabio ^b   Volti, Giovanni Li ^b  

^a Azienda Sanitaria Provinciale di Catania   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Caffeine; Chlorogenic acid; Liver cancer; Liver fibrosis; Liver steatosis

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DESATURASE; ADENOSINE RECEPTOR BLOCKING AGENT; CAFFEINE; CHLOROGENIC ACID; FATTY ACID SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SMAD2 PROTEIN; SMAD3 PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; COFFEE; PLANT EXTRACT;

ADIPOSE TISSUE; ANGIOGENESIS; ANTIOXIDANT ACTIVITY; BILE DUCT LIGATION; BODY MASS; CHRONIC LIVER DISEASE; COFFEA ARABICA; COFFEA CANEPHORA; COFFEE; FATTY LIVER; HUMAN; LIPID DIET; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER PROTECTION; META ANALYSIS (TOPIC); NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OXIDATIVE STRESS; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW (TOPIC); ANIMAL; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; LIPID METABOLISM; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; METABOLISM;

ANIMALS; CAFFEINE; CHLOROGENIC ACID; COFFEE; DISEASE MODELS, ANIMAL; FATTY LIVER; HUMANS; LIPID METABOLISM; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; PLANT EXTRACTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85011692250     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9010085     Document Type: Review

References (54)

1. Freedman, N.D., Park, Y., Abnet, C.C., Hollenbeck, A.R., Sinha, R. Association of coffee drinking with total and cause-specific mortality. N. Engl. J. Med. 2012, 366,1891-190-4.
2. Ding, M., Satija, A., Bhupathiraju, S.N., Hu, Y., Sun, Q., Han, J., Lopez-Garcia, E., Willett, W., van Dam, R.M., Hu, F.B. Association of coffee consumption with total and cause-specific mortality in 3 large prospective cohorts, Circulation 2015,132, 2305-2315.
3. Grosso, G., Micek, A., Godos, J., Sciacca, S., Pajak, A., Martinez-Gonzalez, M.A., Giovannucci, E.L., Galvano, F. Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: A dose-response meta-analysis. Eur. J. Epidemiol. 2016.
4. Saab, S., Mallam, D., Cox, G.A., 2nd, Tong, M.J. Impact o. coffee on liver diseases: A systematic review. Liver Int. C014, 34, 495-504.
5. Setiawan, V.W., Wilkens, L.R., Lu, S.C., Hernandez, B.Y., Le Marchand, L., Henderson, B.E. Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the us multiethnic cohort. Gastroenterology 2015,148,118-125.
6. Ding, M., Bhupathiraju, S.N., Chen, M., van Dam, R.M., Hu, F.B. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: A systematic review and a dose-response meta-analysis. Diabetes Care 2014, 37, 569-586.
7. Marventano, S., Salomone, F., Godos, J., Pluchinotta, F., Del Rio, D., Mistretta, A., Grosso, G. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies. Clin. Nutr. 2016.
8. Zelber-Sagi, S., Salomone, F., Webb, M., Lotan, R., Yeshua, H., Halpern, Z., Santo, E., Oren, R., Shibolet, O. Coffee consumption and nonalcoholic fatty liver onset: A prospective study in the general population. Transl. Res. 2015,165, 428-436.
9. Ma, Y., Gao, M., Liu, D. Chlorogenic acid improves high fat diet-induced hepatic steatosis and insulin resistance in mice. Pharm. Res. 2015, 32,1200-1209.
10. Sinha, R.A., Farah, B.L., Singh, B.K., Siddique, M.M., Li, Y., Wu, Y., Ilkayeva, O.R., Gooding, J., Ching, J., Zhou, J., et al. Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice. Hepatology 2014, 59,1366-1380.
11. Salomone, F., Li Volti, G., Vitaglione, P., Morisco, F., Fogliano, V., Zappala, A., Palmigiano, A., Garozzo, D., Caporaso, N., D'Argenio, G., et al. Coffee enhances the expression of chaperones and antioxidant proteins in rats with nonalcoholic fatty liver disease. Transl. Res. 2014,163, 593-602.
12. Ong, K.W., Hsu, A., Tan, B.K. Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation. Biochem. Pharmacol. 2013, 85,1341-1351.
13. Panchal, S.K., Poudyal, H., Waanders, J., Brown, L. Coffee extract attenuates changes in cardiovascular and hepatic structure and function without decreasing obesity in high-carbohydrate, high-fat diet-fed male rats. J. Nutr. 2012,142, 690-697.
14. Murase, T., Misawa, K., Minegishi, Y., Aoki, M., Ominami, H., Suzuki, Y., Shibuya, Y., Hase, T. Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1C and related molecules in C57BL/6J mice. Am. J. Physiol. Endocrinol. Metab. 2011, 300, E122-E133.
15. Vitaglione, P., Morisco, F., Mazzone, G., Amoruso, D.C., Ribecco, M.T., Romano, A., Fogliano, V., Caporaso, N., D'Argenio, G. Coffee reduces liver damage in a rat model of steatohepatitis: The underlying mechanisms and the role of polyphenols and melanoidins. Hepatology 2010, 52,1652-1661.
16. Rodriguez de Sotillo, D.V., Hadley, M. Chlorogenic acid modifies plasma and liver concentrations of: Cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J. Nutr. Biochem. 2002,13, 717-726.
17. Shimoda, H., Seki, E., Aitani, M. Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice. BMC Complement. Altern. Med. 2006, 6, 9.
18. Reagan-Shaw, S., Nihal, M., Ahmad, N. Dose translation from animal to human studies revisited. FASEB J. 2008, 22, 659-661.
19. Garcia-Ruiz, C., Mato, J.M., Vance, D., Kaplowitz, N., Fernandez-Checa, J.C. Acid sphingomyelinase-ceramide system in steatohepatitis: A novel target regulating multiple pathways. J. Hepatol. 2015, 62, 219-233.
20. Freedman, N.D., Everhart, J.E., Lindsay, K.L., Ghany, M.G., Curto, T.M., Shiffman, M.L., Lee, W.M., Lok, A.S., Di Bisceglie, A.M., Bonkovsky, H.L., et al. Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology 2009, 50,1360-1369.
21. Cardin, R., Piciocchi, M., Martines, D., Scribano, L., Petracco, M., Farinati, F. Effects of coffee consumption in chronic hepatitis c: A randomized controlled trial. Dig. Liver Dis. 2013, 45, 499-504.
22. Crozier, T.W., Stalmach, A., Lean, M.E., Crozier, A. Espresso coffees, caffeine and chlorogenic acid intake: Potential health implications. Food Funct. 2012, 3, 30-33.
23. Godos, J., Pluchinotta, F.R., Marventano, S., Buscemi, S., Li Volti, G., Galvano, F., Grosso, G. Coffee components and cardiovascular risk: Beneficial and detrimental effects. Int. J. Food Sci. Nutr. 2014, 65, 925-936.
24. Chan, E.S., Montesinos, M.C., Fernandez, P., Desai, A., Delano, D.L., Yee, H., Reiss, A.B., Pillinger, M.H., Chen, J.F., Schwarzschild, M.A., et al. Adenosine A2A receptors play a role in the pathogenesis of hepatic cirrhosis. Br. J. Pharmacol. 2006,148,1144-1155.
25. Gressner, O.A., Lahme, B., Rehbein, K., Siluschek, M., Weiskirchen, R., Gressner, A.M. Pharmacological application of caffeine inhibits TGF-β-stimulated connective tissue growth factor expression in hepatocytes via PPARy and SMAD2/3-dependent pathways. J. Hepatol. 2008, 49, 758-767.
26. Gressner, O.A., Lahme, B., Siluschek, M., Gressner, A.M. Identification of paraxanthine as the most potent caffeine-derived inhibitor of connective tissue growth factor expression in liver parenchymal cells. Liver Int. 2009, 29, 886-897.
27. Klemmer, I., Yagi, S., Gressner, O.A. Oral application of 1,7-dimethylxanthine (paraxanthine) attenuates the formation of experimental cholestatic liver fibrosis. Hepatol. Res. 2011, 41,1094-1109.
28. Hsu, S.J., Lee, F.Y., Wang, S.S., Hsin, I.F., Lin, T.Y., Huang, H.C., Chang, C.C., Chuang, C.L., Ho, H.L., Lin, H.C., et al. Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats. Hepatology 2015, 61,1672-1684.
29. Wang, Q., Dai, X., Yang, W., Wang, H., Zhao, H., Yang, F., Yang, Y., Li, J., Lv, X. Caffeine protects against alcohol-induced liver fibrosis by dampening the cAMP/PKA/CREB pathway in rat hepatic stellate cells. Int. Immunopharmacol. 2015,25, 340-352.
30. Wang, H., Guan, W., Yang, W., Wang, Q., Zhao, H., Yang, F., Lv, X., Li, J. Caffeine inhibits the activation of hepatic stellate cells induced by acetaldehyde via adenosine A2A receptor mediated by the cAMP/PKA/SRC/ERK1/2/P38 mapk signal pathway. PLoS ONE 2014, 9, e92482.
31. Gordillo-Bastidas, D., Oceguera-Contreras, E., Salazar-Montes, A., Gonzalez-Cuevas, J., Hernandez-Ortega, L.D., Armendariz-Borunda, J. Nrf2 and Snail-1 in the prevention of experimental liver fibrosis by caffeine. World J. Gastroenterol. 2013,19,9020-9033.
32. Shim, S.G., Jun, D.W., Kim, E.K., Saeed, W.K., Lee, K.N., Lee, H.L., Lee, O.Y., Choi, H.S., Yoon, B.C. Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model. J. Gastroenterol. Hepatol. 2013, 28,1877-1884.
33. Shi, H., Dong, L., Jiang, J., Zhao, J., Zhao, G., Dang, X., Lu, X., Jia, M. Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway. Toxicology 2013, 303, 107-114.
34. Shi, H., Dong, L., Dang, X., Liu, Y., Jiang, J., Wang, Y., Lu, X., Guo, X. Effect of chlorogenic acid on lps-induced proinflammatory signaling in hepatic stellate cells. Inflamm. Res. 2013, 62, 581-587.
35. Furtado, K.S., Prado, M.G., Aguiar, E.S.M.A., Dias, M.C., Rivelli, D.P., Rodrigues, M.A., Barbisan, L.F. Coffee and caffeine protect against liver injury induced by thioacetamide in male wistar rats. Basic Clin. Pharmacol. Toxicol. 2012,111,339-347.
36. Arauz, J., Moreno, M.G., Cortes-Reynosa, P., Salazar, E.P., Muriel, P. Coffee attenuates fibrosis by decreasing the expression of TGF-β and CTGF in a murine model of liver damage. J. Appl. Toxicol. 2013, 33, 970-979.
37. Shi, H., Dong, L., Bai, Y., Zhao, J., Zhang, Y., Zhang, L. Chlorogenic acid against carbon tetrachloride-induced liver fibrosis in rats. Eur. J. Pharmacol. 2009, 623,119-124.
38. Bravi, F., Bosetti, C., Tavani, A., Gallus, S., La Vecchia, C. Coffee reduces risk for hepatocellular carcinoma: An updated meta-analysis. Clin. Gastroenterol. Hepatol. 2013,11,1413-1421.
39. Miura, Y., Ono, K., Okauchi, R., Yagasaki, K. Inhibitory effect of coffee on hepatoma proliferation and invasion in culture and on tumor growth, metastasis and abnormal lipoprotein profiles in hepatoma-bearing rats. J. Nutr. Sci. Vitaminol. (Tokyo) 2004, 50, 38-44.
40. Miura, Y., Furuse, T., Yagasaki, K. Inhibitory effect of serum from rats administered with coffee on the proliferation and invasion of rat ascites hepatoma cells. Cytotechnology 1997, 25, 221-225.
41. Tanaka, T., Nishikawa, A., Shima, H., Sugie, S., Shinoda, T., Yoshimi, N., Iwata, H., Mori, H. Inhibitory effects of chlorogenic acid, reserpine, polyprenoic acid (E-5166), or coffee on hepatocarcinogenesis in rats and hamsters. Basic Life Sci. 1990, 52, 429-440.
42. Furtado, K.S., Polletini, J., Dias, M.C., Rodrigues, M.A., Barbisan, L.F. Prevention of rat liver fibrosis and carcinogenesis by coffee and caffeine. Food Chem. Toxicol. 2014, 64, 20-26.
43. Ferk, F., Huber, W.W., Grasl-Kraupp, B., Speer, K., Buchmann, S., Bohacek, R., Misik, M., Edelbauer, L., Knasmuller, S. Protective effects of coffee against induction of DNA damage and pre-neoplastic foci by aflatoxin Bj. Mol. Nutr. Food Res. 2014, 58, 229-238.
44. Katayama, M., Donai, K., Sakakibara, H., Ohtomo, Y., Miyagawa, M., Kuroda, K., Kodama, H., Suzuki, K., Kasai, N., Nishimori, K., et al. Coffee consumption delays the hepatitis and suppresses the inflammation related gene expression in the long-evans cinnamon rat. Clin. Nutr. 2014, 33,302-310.
45. Mori, H., Tanaka, T., Shima, H., Kuniyasu, T., Takahashi, M. Inhibitory effect of chlorogenic acid on methylazoxymethanol acetate-induced carcinogenesis in large intestine and liver of hamsters. Cancer Lett. 1986, 30,49-54.
46. Cavin, C., Marin-Kuan, M., Langouet, S., Bezencon, C., Guignard, G., Verguet, C., Piguet, D., Holzhauser, D., Cornaz, R., Schilter, B. Induction of Nrf2-mediated cellular defenses and alteration of phase I activities as mechanisms of chemoprotective effects of coffee in the liver. Food Chem. Toxicol. 2008, 46, 1239-1248.
47. Higgins, L.G., Cavin, C., Itoh, K., Yamamoto, M., Hayes, J.D. Induction of cancer chemopreventive enzymes by coffee is mediated by transcription factor Nrf2. Evidence that the coffee-specific diterpenes cafestol and kahweol confer protection against acrolein. Toxicol. Appl. Pharmacol. 2008, 226, 328-337.
48. Kalthoff, S., Ehmer, U., Freiberg, N., Manns, M.P., Strassburg, C.P. Coffee induces expression of glucuronosyltransferases by the Aryl hydrocarbon receptor and Nrf2 in liver and stomach. Gastroenterology 2010,139,1699-1710.
49. Vicente, S.J., Ishimoto, E.Y., Torres, E.A. Coffee modulates transcription factor Nrf2 and highly increases the activity of antioxidant enzymes in rats. J. Agric. Food Chem. 2014, 62,116-122.
50. Lecoultre, V., Carrel, G., Egli, L., Binnert, C., Boss, A., MacMillan, E.L., Kreis, R., Boesch, C., Darimont, C., Tappy, L. Coffee consumption attenuates short-term fructose-induced liver insulin resistance in healthy men. Am. J. Clin. Nutr. 2014, 99, 268-275.
51. Nardini, M., Cirillo, E., Natella, F., Scaccini, C. Absorption of phenolic acids in humans after coffee consumption. J. Agric. Food Chem. 2002,50,5735-5741.
52. Rechner, A.R., Spencer, J.P., Kuhnle, G., Hahn, U., Rice-Evans, C.A. Novel biomarkers of the metabolism of caffeic acid derivatives in vivo. Free Radic. Biol. Med. 2001, 30,1213-1222.
53. Monteiro, M., Farah, A., Perrone, D., Trugo, L.C., Donangelo, C. Chlorogenic acid compounds from coffee are differentially absorbed and metabolized in humans. J. Nutr. 2007,137,2196-2201.
54. Stalmach, A., Steiling, H., Williamson, G., Crozier, A. Bioavailability of chlorogenic acids following acute ingestion of coffee by humans with an ileostomy. Arch. Biochem. Biophys. 2010, 501, 98-105.